Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

NCT00103376 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Prostate Cancer

Interventions

DRUG: Velcade
DRUG: LH-RH Agonist
DRUG: Androgen Receptor Antagonists

Sponsor

Medical University of South Carolina